Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced that management plans to attend three investor conferences in August.
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to attend three investor conferences in August.
Guggenheim MedTech Disruptors Summit
Tuesday, August 10, 2021
Canaccord Genuity 41st Annual Growth Conference
Wednesday, August 11, 2021
12:30 p.m. ET
Webcast of presentation
6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
Tuesday, August 17, 2021
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210727005130/en/
Cardiovascular Systems, Inc.
Jack Nielsen
Vice President, Investor Relations
& Corporate Communications
(651) 202-4919
j.nielsen@csi360.com
Source: Cardiovascular Systems, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20210727005130/en
